Guest editors: Giuseppe Leone and Lodovico Balducci
Perspectives
TREATMENT OF CANCER IN THE OLDER AGED PERSON
Abstract 814 | PDF Downloads 587 HTML Downloads 3283 | DOI https://doi.org/10.4084/mjhid.2010.029Page e2010029
Review Articles
ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Abstract 685 | PDF Downloads 364 HTML Downloads 2153 | DOI https://doi.org/10.4084/mjhid.2010.015Page e2010015
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
Abstract 1097 | PDF Downloads 519 HTML Downloads 2176 | DOI https://doi.org/10.4084/mjhid.2010.017Page e2010017
OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE
Abstract 966 | PDF Downloads 559 HTML Downloads 702 | DOI https://doi.org/10.4084/mjhid.2010.010Page e2010010
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Abstract 1301 | PDF Downloads 413 HTML Downloads 2316 | DOI https://doi.org/10.4084/mjhid.2010.011Page e2010011
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Abstract 972 | PDF Downloads 534 HTML Downloads 878 | DOI https://doi.org/10.4084/mjhid.2010.026Page e2010026
THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
Abstract 764 | PDF Downloads 406 HTML Downloads 522 | DOI https://doi.org/10.4084/mjhid.2010.009Page e2010009
"ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"
Abstract 851 | PDF Downloads 426 HTML Downloads 1420 | DOI https://doi.org/10.4084/mjhid.2010.013Page e2010013
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
Abstract 914 | PDF Downloads 488 HTML Downloads 629 | DOI https://doi.org/10.4084/mjhid.2010.021Page e2010021
ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
Abstract 862 | PDF Downloads 354 HTML Downloads 1096 | DOI https://doi.org/10.4084/mjhid.2010.019Page e2010019
How I Treat
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?
Abstract 885 | PDF Downloads 553 HTML Downloads 468 | DOI https://doi.org/10.4084/mjhid.2010.018Page e2010018
Original Articles
POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE
Abstract 873 | PDF Downloads 505 HTML Downloads 498 | DOI https://doi.org/10.4084/mjhid.2010.016Page e2010016
CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY
Abstract 851 | PDF Downloads 561 HTML Downloads 1065 | DOI https://doi.org/10.4084/mjhid.2010.020Page e2010020
Case Reports
PHENYTOIN-ASSOCIATED LYMPHOADENOPATHY MIMICKING A PERIPHERAL T-CELL LYMPHOMA
Abstract 860 | PDF Downloads 580 HTML Downloads 5360 | DOI https://doi.org/10.4084/mjhid.2010.028Page e2010028
Letters to the Editor
Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
Abstract 806 | PDF Downloads 455 HTML Downloads 299 | DOI https://doi.org/10.4084/mjhid.2010.012Page e2010012